Recent supply disruptions at key mines have the copper price flying high, but will they have a lasting impact?
Supply concerns bumped the red metal’s price up 2 percent on Wednesday.
Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U. S. Food and Drug Administration (FDA) has granted Fast Track designation to FCX-007, the Company’s clinical-stage candidate for the treatment of Recessive Dystrophic Epidermolysis Bullosa
Fibrocell Science today announced the appointment of Alfred T. Lane, MD, as Chief Medical Advisor of Fibrocell.
Fibrocell Science, a relatively small gene therapy company, just closed a huge financing deal: it received $18.1 million after selling convertible promissory notes and warrants, most of which will go to funding products currently in development.
Gecamines bids on Freeport’s stakes for Tenke, one of the largest copper mines in the world.